Lantheus Holdings, Inc.
Supplemental Revenue Information
(unaudited)
Beginning with the first quarter of 2021, the Company changed its product revenues presentation, where product revenues are n ow presented net of rebates and allowances. Rebates and allowances for DEFINITY and TechneLite comprised approximately 98% of the Company's total rebates and allowances for the years ended 2020 and 2019.
The below table presents quarterly revenues for DEFINITY and TechneLite for the respective years:
|
Gross Revenue - Excluding Rebates and Allowances |
||||||||||||||||||||||||||||||||||||||||
|
2019 |
2020 |
|||||||||||||||||||||||||||||||||||||||
|
(in millions) |
Q1 |
Q2 |
Q3 |
Q4 |
Total |
Q1 |
Q2 |
Q3 |
Q4 |
Total |
||||||||||||||||||||||||||||||
|
DEFINITY |
$ |
51.1 |
$ |
54.6 |
$ |
52.4 |
$ |
59.4 |
$ |
217.5 |
$ |
56.8 |
$ |
40.4 |
$ |
55.4 |
$ |
60.7 |
$ |
213.3 |
||||||||||||||||||||
|
TechneLite |
24.1 |
20.1 |
21.7 |
20.6 |
86.5 |
23.1 |
18.9 |
21.5 |
22.7 |
86.2 |
||||||||||||||||||||||||||||||
|
Growth Rate % |
||||||||||||||||||||||||||||||||||||||||
|
DEFINITY |
14.5 |
% |
18.5 |
% |
19.7 |
% |
22.3 |
% |
18.8 |
% |
11.1 |
% |
(26.1) |
% |
5.8 |
% |
2.3 |
% |
(1.9) |
% |
||||||||||||||||||||
|
TechneLite |
12.9 |
% |
(14.4) |
% |
(29.0) |
% |
(11.9) |
% |
(12.4) |
% |
(4.3) |
% |
(6.0) |
% |
(1.2) |
% |
10.4 |
% |
(0.4) |
% |
|
Net Revenue - Including Rebates and Allowances |
||||||||||||||||||||||||||||||||||||||||
|
2019 |
2020 |
|||||||||||||||||||||||||||||||||||||||
|
(in millions) |
Q1 |
Q2 |
Q3 |
Q4 |
Total |
Q1 |
Q2 |
Q3 |
Q4 |
Total |
||||||||||||||||||||||||||||||
|
DEFINITY |
$ |
47.6 |
$ |
50.7 |
$ |
48.8 |
$ |
55.3 |
$ |
202.4 |
$ |
52.5 |
$ |
37.1 |
$ |
50.4 |
$ |
55.9 |
$ |
195.9 |
||||||||||||||||||||
|
TechneLite |
23.9 |
19.8 |
21.5 |
20.3 |
85.5 |
22.8 |
18.7 |
21.1 |
22.4 |
85.0 |
||||||||||||||||||||||||||||||
|
Growth Rate % |
||||||||||||||||||||||||||||||||||||||||
|
DEFINITY |
13.3 |
% |
17.9 |
% |
19.1 |
% |
21.8 |
% |
18.1 |
% |
10.4 |
% |
(26.8) |
% |
3.2 |
% |
1.2 |
% |
(3.2) |
% |
||||||||||||||||||||
|
TechneLite |
12.7 |
% |
(14.8)% |
(29.4)% |
(12.3)% |
(12.8)% |
(4.6)% |
(5.8)% |
(1.7)% |
10.3 % |
(0.6)% |
Page 1 of 9
Lantheus Holdings, Inc.
Supplemental Net Revenue Information
(unaudited)
Beginning with the first quarter of 2021, the Company changed its product revenues presentation.
The below table presents quarterly revenues for the respective years:
|
Net Revenue - Including Rebates and Allowances |
||||||||||||||||||||||||||||||||||||||||||
|
2019 |
2020 |
|||||||||||||||||||||||||||||||||||||||||
|
(in millions) |
Q1 |
Q2 |
Q3 |
Q4 |
Total |
Q1 |
Q2 |
Q3 |
Q4 |
Total |
||||||||||||||||||||||||||||||||
|
DEFINITY |
$ |
47.6 |
$ |
50.7 |
$ |
48.8 |
$ |
55.3 |
$ |
202.4 |
$ |
52.5 |
$ |
37.1 |
$ |
50.4 |
$ |
55.9 |
$ |
195.9 |
||||||||||||||||||||||
|
TechneLite |
23.9 |
19.8 |
21.5 |
20.3 |
85.5 |
22.8 |
18.7 |
21.1 |
22.4 |
85.0 |
||||||||||||||||||||||||||||||||
|
Other precision diagnostics |
12.5 |
12.4 |
12.8 |
11.4 |
49.1 |
13.0 |
7.1 |
8.6 |
8.0 |
36.7 |
||||||||||||||||||||||||||||||||
|
Total precision diagnostics |
84.0 |
82.9 |
83.1 |
87.0 |
337.0 |
88.3 |
62.9 |
80.1 |
86.3 |
317.6 |
||||||||||||||||||||||||||||||||
|
Radiopharmaceutical oncology |
2.1 |
2.4 |
2.3 |
1.9 |
8.7 |
2.0 |
2.2 |
3.3 |
2.6 |
10.1 |
||||||||||||||||||||||||||||||||
|
Strategic partnerships and other |
0.4 |
0.4 |
0.4 |
0.4 |
1.6 |
0.4 |
0.9 |
5.1 |
5.3 |
11.7 |
||||||||||||||||||||||||||||||||
|
Total revenues |
$ |
86.5 |
$ |
85.7 |
$ |
85.8 |
$ |
89.3 |
$ |
347.3 |
$ |
90.7 |
$ |
66.0 |
$ |
88.5 |
$ |
94.2 |
$ |
339.4 |
||||||||||||||||||||||
Page 2 of 9
Attachments
Disclaimer
Lantheus Holdings Inc. published this content on 04 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 May 2021 11:10:14 UTC.